Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Renal damage during type I cryoglobulinemia].

Frank Bridoux1, François Provôt, Ramzi Abou Ayache

  • 1Service de néphrologie, hémodialyse et transplantation rénale, Hôpital Jean Bernard, CHU Poitiers. f.bridoux@chu-poitiers.fr

Presse Medicale (Paris, France : 1983)
|April 26, 2003
PubMed
Summary

Type I cryoglobulinemia can cause kidney damage similar to mixed cryoglobulinemia. Effective treatment for the underlying blood cancer often improves kidney function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factor X colocalizes with amyloid light chain deposits in AL amyloidosis: evidence from three patients.

Haematologica·2026
Same author

Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Real-world management of tuberous sclerosis complex-associated renal angiomyolipomas: the impact of mTOR inhibitors.

Clinical kidney journal·2026
Same author

The STING HAQ haplotype and clinical non-penetrance in COPA syndrome.

The Journal of experimental medicine·2026
Same author

Clinicopathological Spectrum and Treatment Outcomes of Cryofibrinogen-Associated Nephropathies.

Kidney international reports·2026
Same author

Ethnicity affects relapse-free survival in immunemediated thrombotic thrombocytopenic purpura.

Haematologica·2026

Area of Science:

  • Nephrology
  • Hematology
  • Immunology

Background:

  • Type I cryoglobulinemia, characterized by a single monoclonal immunoglobulin, can lead to glomerulopathy.
  • This renal damage shares clinical and histological features with mixed cryoglobulinemia.
  • Type I cryoglobulins are frequently associated with hematological malignancies, such as chronic lymphoid leukemia or non-Hodgkin's lymphoma, in 60% of cases.

Purpose of the Study:

  • To characterize the renal manifestations of Type I cryoglobulinemia.
  • To explore the relationship between Type I cryoglobulinemia and underlying hematological diseases.
  • To evaluate treatment outcomes for renal and hematological aspects of Type I cryoglobulinemia.

Main Methods:

  • Clinical case review and histological analysis of renal biopsies.

Related Experiment Videos

  • Assessment of cryoglobulin type and association with hematological disorders.
  • Monitoring of renal function and hematological disease status during treatment.

    • Main Results:

    • Type I cryoglobulinemia presents with glomerulopathy mimicking mixed cryoglobulinemia.
    • A significant proportion of Type I cryoglobulinemia cases are linked to hematological malignancies.
    • Treatment targeting the hematological disease, using corticosteroids, immunosuppressors, or antimitotics, often results in parallel stabilization or remission of renal and hematological manifestations.

    Conclusions:

    • Type I cryoglobulinemia is a significant cause of glomerulopathy with distinct clinical and histological profiles.
    • Management of the underlying hematological malignancy is crucial for addressing renal complications.
    • Combined therapeutic strategies can lead to favorable outcomes for both renal and hematological aspects of the disease.